CCL2 and metabolic syndrome: As expected, MetS patients had significantly higher levels of BMI, waist circumference, fat%, SBP, DBP, TG, FIns, FPG, 2h-PG, HOMA-IR, IL-6, and MCP-1 and lower HDL-C than those of the controls (P < 0.01 or P < 0.05).